Dermatomyositis - Pipeline Review H1 2016 Telephone: +1 (800) 910-6452 Mail at: sales@researchbeam.com
Report Overview ‘Dermatomyositis - Pipeline Review, H1 2016’, provides an overview of the Dermatomyositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dermatomyositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dermatomyositis and features dormant and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Strategic Focus Report: http://www.researchbeam.com/dermatomyositis-pipeline-review-h1-2016market
Report Overview Scope - The report provides a snapshot of the global therapeutic landscape of Dermatomyositis - The report reviews pipeline therapeutics for Dermatomyositis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Dermatomyositis - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Dermatomyositis Overview 6 Therapeutics Development 7 Pipeline Products for Dermatomyositis - Overview 7 Dermatomyositis - Therapeutics under Development by Companies 8 Dermatomyositis - Pipeline Products Glance 9 Clinical Stage Products 9 Early Stage Products 10 Dermatomyositis - Products under Development by Companies 11 Dermatomyositis - Companies Involved in Therapeutics Development 12 F. Hoffmann-La Roche Ltd. 12 Hope Pharmaceuticals, Inc. 13 Idera Pharmaceuticals, Inc. 14 MedImmune, LLC 15 Neovacs SA 16 Novartis AG 17 Dermatomyositis - Therapeutics Assessment 18 Assessment by Monotherapy Products 18 Assessment by Target 19
Report Ordering
Report Name: Dermatomyositis - Pipeline Review H1 2016
Product Price User
Price
Single User
US $ 1700
Site User
US $ 4000
Global User
US $ 6000
To View Sample or Purchase Report
Contact Us
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/dermatomyositis-pipeline-review-h1-2016-market
Stay With Us At:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States